In vitro, MCL-1 inhibition sensitised neuroblastoma cells to ABT-199 treatment, highlighting the protective role MCL-1 mediates in cells with high BCL-2:BIM complex levels [78]. Here, BCL2L11 is linked to neuroblastoma.